Inhibition of B-Raf or MEK in B-Raf–mutant cancer cells suppresses ERK activation accompanied by downregulation of DR5 expression and decreased cell sensitivity to DR5 activation-induced apoptosis, as we recently demonstrated21. This evidence concerns the gene MAP2K7 and cancer.